(Q33384990)
Statements
1 reference
Phase II study of the proteasome inhibitor bortezomib (PS-341, Velcade) in chemotherapy-naïve patients with advanced stage non-small cell lung cancer (NSCLC). (English)
1 reference
Tianhong Li
1 reference
Liawaty Ho
1 reference
Bilal Piperdi
1 reference
Tarek Elrafei
1 reference
Fernando J Camacho
1 reference
James R Rigas
1 reference
Roman Perez-Soler
1 reference
Rasim Gucalp
1 reference
12 June 2009
1 reference
1 reference
68
1 reference
89-93
1 reference
Identifiers
1 reference
1 reference